Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Kisspeptin-10

KP-10, Metastin (45-54), Kisspeptin-10 (human), KiSS-1

Quick Stats
Studies 877
Trials 47
Score 3
2012 pubmed 88 citations

Kisspeptin administration to women: a window into endogenous kisspeptin secretion and GnRH responsiveness across the menstrual cycle.

Chan. Yee-Ming YM; Butler. James P JP; Sidhoum. Valerie F VF; Pinnell. Nancy E NE; Seminara. Stephanie B SB

Key Findings

  • Kisspeptin caused immediate LH pulses in all luteal and pre‑ovulatory women, but only in about half of early follicular women.
  • Increasing the kisspeptin dose from 0.24 to 0.72 nmol/kg did not improve the LH response in early‑follicular participants.
  • Kisspeptin did not reset the GnRH pulse generator in women as it does in men, indicating sex‑specific regulation.

Practical Outcomes

  • For self‑experimenters aiming to modulate reproductive hormones, timing matters: kisspeptin is most effective at boosting LH during the mid‑luteal or pre‑ovulatory window, not right after menstruation. Raising the dose won’t overcome a weak early‑follicular response, so higher amounts are unlikely to be beneficial. This insight can guide when to schedule kisspeptin‑based protocols if the goal is to influence ovulation or luteal phase hormone levels.

Summary

Giving kisspeptin to women triggers a quick rise in LH (the hormone that tells the ovaries to release eggs) but only when they are in the mid‑luteal or pre‑ovulatory part of their cycle. In the early follicular phase (right after the period starts) the response is weak and giving more kisspeptin doesn’t help. This means the body’s own kisspeptin levels are already high early in the cycle, so extra kisspeptin doesn’t add much.

Abstract

Kisspeptin is the most powerful known stimulus of GnRH-induced LH secretion across mammalian species. However, the effects of kisspeptin are just being explored, and the dynamics of kisspeptin responsiveness across the menstrual cycle are incompletely understood. The objective of the study was to characterize the effects of kisspeptin on GnRH secretion in healthy women in different phases of the menstrual cycle. Ten women in the early follicular phase, three women in the late follicular (preovulatory) phase, and 14 women in the midluteal phase received a bolus of kisspeptin 112-121 0.24 nmol/kg iv. An additional four women in the early to midfollicular phase received kisspeptin 112-121 0.72 nmol/kg iv. The response to kisspeptin varied depending on the phase of the menstrual cycle. LH pulses were observed immediately after kisspeptin administration in all luteal and preovulatory women. However, only half the women in the early follicular phase had unambiguous kisspeptin responses. Increasing the kisspeptin dose did not increase the LH response in early to midfollicular phase women. Kisspeptin did not appear to reset the GnRH pulse generator in women as it does in men. Differences in responses to exogenous kisspeptin across the menstrual cycle suggest that kisspeptin tone is higher in the early follicular phase compared with other cycle phases. The mechanisms that determine the timing of GnRH pulse generation in men and women appear to be distinct.

Study Information

Provider

pubmed

Year

2012

Date

2012-05-10T00:00:00.000Z

DOI

10.1210/jc.2012-1282

Citations

88

References

43